LBRX: Kozauer Susan Gani reports a stock award

By AlphaYouPublished Oct 13, 2026Form 4

Stocks in this disclosure

Reported activity

Kozauer Susan Gani

Reporting filer

Kozauer Susan Gani reports a stock award, not an open-market purchase or sale, in Lb Pharmaceuticals Inc. Form 4 filed Oct 13, 2026 lists 1 entry.

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Emplopyee Stock Option (Right to Buy) (derivative)	Kozauer Susan Gani	2026-10-09	A	Grant or award	200000	0	200,000	4 days	Filed terms security Title: Emplopyee Stock Option (Right to Buy) conversion Or Exercise Price: 37.22 transaction Date: 2026-10-09 transaction Form Type: 4 transaction Code: A equity Swap Involved: 0 transaction Shares: 200000 transaction Price Per Share: 0 transaction Acquired Disposed Code: A id: F1 expiration Date: 2036-10-08 underlying Security Title: Common Stock underlying Security Shares: 200000 shares Owned Following Transaction: 200000 direct Or Indirect Ownership: D nature Of Ownership:

Owner: Kozauer Susan Gani
Date: 2026-10-09
Code: A
Action: Grant or award
Quantity: 200000
Price: 0
Following holdings: 200,000
Reporting delay: 4 days
Filed terms and references: Filed terms
security Title: Emplopyee Stock Option (Right to Buy)
conversion Or Exercise Price: 37.22
transaction Date: 2026-10-09
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Shares: 200000
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
id: F1
expiration Date: 2036-10-08
underlying Security Title: Common Stock
underlying Security Shares: 200000
shares Owned Following Transaction: 200000
direct Or Indirect Ownership: D
nature Of Ownership:

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Kozauer Susan Gani: Chief Medical Officer.
F1: One fourth (1/4th) of the shares subject to the option award shall vest on September 14, 2027, and the remaining shares subject to the option award shall vest over the following three years on a monthly basis on the last day of the month commencing on September 30, 2027, subject to the Reporting Person's continuous service through such vesting date.

Prepared automatically from public filing data. Report a correction.